Related Experiment Videos
Respiratory support in paediatric patients with bronchiolitis: a systematic review and meta-analysis
Spyridon Karageorgos1,2, Anastasios Panagiotis Chantzaras3, Aris P Agouridis4,5
1Faculty of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK.
Background:
Recent evidence suggests that high-flow nasal cannula (HFNC) may confer better clinical outcomes compared with other respiratory support modalities in paediatric patients with bronchiolitis.
Methods:
We performed a literature search up to 21 January 2024 on PubMed, Scopus, Cochrane Library, Embase, Cumulative Index to Nursing and Allied Health Literature, World Health Organization International Clinical Trials Registry Platform and Clinicaltrials.gov. Randomised controlled studies including paediatric patients aged ≤24 months with bronchiolitis comparing the use of HFNC versus low-flow nasal cannula (LFNC) or continuous positive airway pressure (CPAP) were included. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. Random-effect modelling was used to estimate pooled effects.
Results:
18 studies with 4094 patients were included. HFNC did not reduce the need for mechanical ventilation compared to LFNC (risk ratio 0.69, 95% CI 0.33-1.44; p=0.32) or CPAP (risk ratio 0.90, 95% CI 0.65-1.24; p=0.52). HFNC resulted in less treatment failure compared to LFNC (risk ratio 0.44, 95% CI 0.23-0.87; p=0.02), whereas there was no difference compared to CPAP (risk ratio 1.28, 95% CI 0.90-1.80; p=0.17). HFNC was associated with significant reduction in length of paediatric intensive care unit (PICU) stay compared to LFNC (mean difference (MD) -0.40 95% CI -0.78- -0.02; p=0.04), but not compared to CPAP (MD -0.24, 95% CI -0.91-0.43; p=0.47).
Interpretation:
HFNC significantly reduced treatment failure, length of PICU stay and total oxygen therapy duration compared to LFNC. No differences between HFNC and CPAP in primary and secondary outcomes. HFNC could be considered as initial treatment modality in paediatric patients with bronchiolitis, especially in patients requiring escalation of treatment from LFNC.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Pulmonary Cycle: Exhalation
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
COPD: Management Using Bronchodilators and Corticosteroids